According the the AP, results for children on this are still not available. Since news of the vaccine has come out in the last several months, it has been thought that 2 shots would be needed.
As a result, the vaccine will be available to more people in the high risk groups, including pregnant women, children, teens and childcare workers. In addition, vaccines will likely now be available in poorer countries, where before this was unknown.
According to the Times, "“This is definitely a big deal,” said Dr. John J. Treanor, a vaccine expert at the University of Rochester. “People had been planning for a scenario that would require two doses.”
“This will take the edge off the nail-biting,” Dr. Treanor added.
The results released Thursday were based on the first three weeks of a clinical trial. Healthy adults got one 15-microgram shot, and their blood was tested 21 days later. By that time, 97 percent of the 120 adults had enough antibodies to be considered protected. Another group that got 30-microgram doses had no greater protection.
There were no deaths or dangerous side-effects. Almost half of the participants reported sore arms or headaches, but that is normal with flu shots."
To avoid thimerosal ask for the single dose of the shot, which is not supposed to contain this preservative. The vaccine should be available in the middle of October.
We'll hear soon if the same is true for the vaccine in children.
Katy can be found at Non-Toxic Kids sharing helpful information about how to raise kids as naturally as possible. She is a teacher, freelance writer, and mama from the mountains of Vermont.
